Orchid Pharma completes USFDA inspection at Alathur API facility with seven minor observations Read more
Gaps in brand availability impact India’s pharmaceutical distribution: Vector Consulting Group report Read more
Fragile X syndrome market to quadruple to $111.9 million in US and Germany by 2030, forecasts GlobalData Read more
Sun Pharma amongst top 5% of global pharma companies in S&P Global Sustainability Yearbook 2025 Read more
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData Read more